Fagron is focused on the optimisation and innovation of pharmaceutical compounding
As an R&D scientific pharmaceutical compounding company, our objective is to widen the therapeutic scope of the prescriber to enable tailor-made pharmaceutical care.
Fagron was founded in Rotterdam (the Netherlands) in 1990 by Ger van Jeveren, CEO of the Fagron Group. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron quickly became the market leader in the Netherlands.
Ger van Jeveren continued to direct further development and international growth, with the result that Fagron is currently the global market leader and is active in 32 countries in Europe, the Americas, Africa, the Middle East, Asia and the Pacific.
Fagron products are sold to 200,000 customers in over 60 countries around the world. Over 300 Fagron pharmacists are continually developing new, unique products and concepts to meet the growing worldwide need for tailor-made medication.
Fagron South Africa
The Fagron compounding pharmacies in Cape Town (Rausa-kem), Johannesburg (Dynaceuticals) and George (Mar-Kem) have served doctors and patients since 1995. Fagron South Africa is well established as a respected partner and leader in the pharmaceutical compounding industry.
Fagron entered the South African market through acquisition of key compounding pharmacies in Cape Town, George and Johannesburg. In 2014, Fagron acquired Dynaceuticals, a compounding pharmacy in Gauteng, which is headed by three dynamic professionals. In 2015, Fagron acquired Rausa-kem, which is headed by Professor Reinhard Uebel with 20 years of sterile compounding experience, Reakiri, the marketing and sales arm of Rausa-kem, and MarKem, a sterile compounding pharmacy in George. This powerful combination has created a unique, national organisation serving both doctors and patients all over the country.
Our team of pharmacists is headed by Professor Reinhard Uebel, who graduated with a BPharm in 1982 and completed his PhD in 1994. He lectured pharmacology at the University of Stellenbosch and Pharmaceutics at UWC. Professor Uebel is the author of a number of research publications.
Fagron South Africa compounds high-quality, cost-effective, customised, proven formulations of medications that are not available from a pharmaceutical drug company.